pocketful logo
Mercury Laboratories Ltd logo

Mercury Laboratories Ltd

NSE: BSE: 538964

780

(1.04%)

Fri, 13 Mar 2026, 05:46 am

Mercury Laboratories News

Mercury Labs Q3FY26 Net Profit Drops 16.4% to ₹99.75 Cr

Mercury Laboratories reported Q3FY26 net profit of ₹99.75 lakhs, down 16.4% YoY, despite revenue declining 6.2% to ₹1,835.03 lakhs. Nine-month performance showed strong recovery.

11 Feb 2026

co actions results

Mercury Laboratories Assigns Additional VP Role to Chief Operating Officer

Mercury Laboratories Limited has assigned an additional role of Vice President-Marketing Sales to Saurabh Mittal, who serves as Chief Operating Officer, effective November 17, 2025. The appointment involves a senior management personnel with over 15 years of corporate experience in marketing, business development, and system processes across established and start-up organizations.

17 Nov 2025

corporate governance

Mercury Laboratories Delays New Injectable Plant Commissioning by 13 Months to December 2026

Mercury Laboratories has deferred the commissioning of its new Small Volume Parenteral (SVPs) manufacturing plant by 13 months from the originally scheduled November 2025 to December 2026. The plant, located at Jarod with a capacity to manufacture 75 million units annually, involves an estimated cost of INR 30 crores. The delay is attributed to revisions in Schedule M guidelines by the Ministry of Health and Family Welfare, which mandated additional compliance and infrastructural requirements for pharmaceutical manufacturing facilities. The company states there is no material adverse impact on overall business operations due to the delay and is taking necessary steps to expedite project completion.

12 Nov 2025

stock

Mercury Laboratories Reports 69% Jump in Quarterly Net Profit to Rs 164.33 Lakhs

Mercury Laboratories Limited announced its unaudited financial results for the quarter and half year ended September 30, 2025. The pharmaceutical company reported a net profit after tax of Rs 164.33 lakhs for the quarter, compared to Rs 96.76 lakhs in the previous quarter, representing a significant increase. Revenue from operations for the quarter stood at Rs 1,900.86 lakhs, up from Rs 1,813.54 lakhs in the previous quarter. For the half year period, net profit reached Rs 261.09 lakhs with revenue from operations at Rs 3,714.40 lakhs. The company's total comprehensive income for the quarter was Rs 164.00 lakhs. Basic earnings per share for the quarter was Rs 13.69 compared to Rs 8.06 in the previous quarter. The Board of Directors approved these results at their meeting held on November 11, 2025. The company operates in a single segment of pharmaceutical products and has paid-up equity share capital of Rs 120.00 lakhs with face value of Rs 10 per share.

12 Nov 2025

earnings

Mercury Laboratories Appoints Seema Salvi as Head of Injectable Production Department

Mercury Laboratories Limited appointed Ms. Seema Salvi as Head of the Injectable Production Department effective November 04, 2025. Salvi, aged 49, holds a Bachelor's degree in Pharmacy and brings over 26 years of experience in injection production. She was previously associated with Harson Laboratories India Pvt. Ltd. and Crescent Labs Pvt Ltd. The appointment is for full-time employment as part of the company's senior management personnel changes.

04 Nov 2025

corporate governance

Showing 15 of 7
Rows per page:

Market Current News

Japan to Join U.S. Missile Defense System - Yomiuri

Japan is set to join the U.S. missile defense system, with the announcement expected at an upcoming summit, according to Yomiuri reports.

12 Mar 2026

global

Bessent: Trump-Starmer Ties to Improve, US Economy at 3%

Treasury Secretary Bessent says Trump-Starmer relationship will recover while confirming Iran hasn't mined Strait of Hormuz. Projects 3% US economic growth post-Iran conflict resolution.

12 Mar 2026

global

CME Warns Against U.S. Oil Futures Intervention

CME Group has cautioned that U.S. government intervention in oil futures markets would constitute a 'biblical disaster,' highlighting concerns about market stability and regulatory overreach.

12 Mar 2026

commodities

Netanyahu: Israel Aims to Prevent Iran Nuclear Projects

Israeli PM Netanyahu states Iran has changed significantly and declares Israel's intention to prevent Iran from moving nuclear and ballistic missile projects underground.

12 Mar 2026

global

Netanyahu: Israel Targeting Iranian Forces

Israeli PM Netanyahu declares Israel is dealing heavy blows to Iran's Revolutionary Guard and Basij forces in ongoing military operations.

12 Mar 2026

global

Showing 15 of 91991
Rows per page:

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800